Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FDA3A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $64,920
Award facts
- Contract value 100% obligated
- $64,920.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $64,920 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packaging) on January 16, 2026, with completion expected by January 20, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2031, which serves as a comprehensive global pharmaceutical supply vehicle supporting military healthcare programs worldwide.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting Defense Health Agency and military treatment facilities. The parent company, Cencora, Inc., maintains significant IDC relationships with both the Defense Logistics Agency and the Department of Justice Federal Bureau of Investigation for the delivery of prescription medications, specialty pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains. Ondansetron, an anti-nausea medication commonly used in clinical settings, represents the type of essential pharmaceutical commodity routinely delivered through these federal contracts to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FDA3A?
SPE2DR26FDA3A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FDA3A worth?
The government has obligated $64,920 on SPE2DR26FDA3A.
Is contract SPE2DR26FDA3A an order under another contract?
Yes. SPE2DR26FDA3A is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDA3A competed?
The extent of competition for SPE2DR26FDA3A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award